Market revenue in 2024 | USD 5,910.5 million |
Market revenue in 2030 | USD 11,428.5 million |
Growth rate | 11.7% (CAGR from 2025 to 2030) |
Largest segment | Psoriasis |
Fastest growing segment | Psoriasis |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 40.18% in 2024. Horizon Databook has segmented the Asia Pacific dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
The dermatological drugs market in the Asia Pacific region is experiencing steady growth. The increasing prevalence of skin diseases, including acne, eczema, and psoriasis, is a significant factor contributing to market expansion. The growing awareness of dermatological conditions, coupled with the rising disposable income in several countries, is driving the demand for both prescription and over-the-counter dermatology products.
Governments in the region are also taking steps to improve healthcare infrastructure, which is further facilitating market growth. Key drivers of the dermatological drugs market in the Asia Pacific include the rising burden of skin diseases, advancements in dermatological treatments, and an increasing focus on improving healthcare systems.
The growing geriatric population, which is more prone to skin-related conditions, is also contributing to the market's expansion. Moreover, the increasing adoption of advanced technologies and the introduction of new, more effective treatments are expected to drive further growth in the dermatological drugs market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific dermatological drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account